Pseudohypoparathyroidism secondary prevention

	Pseudohypoparathyroidism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pseudohypoparathyroidism from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pseudohypoparathyroidism secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pseudohypoparathyroidism secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pseudohypoparathyroidism secondary prevention
CDC on Pseudohypoparathyroidism secondary prevention
Pseudohypoparathyroidism secondary prevention in the news
Blogs on Pseudohypoparathyroidism secondary prevention
Directions to Hospitals Treating Pseudohypoparathyroidism
Risk calculators and risk factors for Pseudohypoparathyroidism secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]

Overview

Secondary prevention of measures in pseudohypoparathyroidism include regular serum and urinary calcium measurements monitoring.

Secondary prevention measures in pseudohypoparathyroidism include:^[1]

Monitor therapy with regular serum and urinary calcium measurements
Pseudohypoparathyroidism type 1b patients at an increased risk of developing hyperparathyroidism and hyperparathyroid bone disease should be maintained at sufficient doses of calcium and vitamin D to maintain serum calcium and PTH levels within the normal range.